Zeal Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Zeal Asset Management’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$13.1M	Hold	73,253	–	–	33.29%	2
2023 Q2	$13.1M	Sell	73,253 -66,651	-48%	-$15.3M	63%	1
2023 Q1	$30.4M	Hold	139,904	–	–	70.32%	1
2022 Q4	$31.1M	Hold	139,904	–	–	67.28%	1
2022 Q3	$18.9M	Sell	139,904 -49,943	-26%	-$8.58M	64.5%	1
2022 Q2	$29.6M	Sell	189,847 -4,991	-3%	-$780K	60.99%	1
2022 Q1	$38.1M	Buy	194,838 +141,646	+266%	+$30.1M	49.65%	1
2021 Q4	$14.4M	Buy	+53,192	New	+$18M	8.68%	3

Other funds holding ONC

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Zeal Asset Management's ONC Position: Q3 2023 in Review

Zeal Asset Management held its BeOne Medicines Ltd (ONC) position steady in Q3 2023 at 73,253 shares worth $13.1M. The position accounts for 33.29% of the portfolio, ranked #2.

Zeal Asset Management first reported a position in ONC in Q4 2021 and has held it in 8 quarters since. The position peaked at $38.1M in Q1 2022. 201 funds tracked by Wall St. Rank hold ONC as of Q3 2023.

Zeal Asset Management held 73,253 shares of BeOne Medicines Ltd worth $13.1M as of Q3 2023.
Zeal Asset Management left its BeOne Medicines Ltd share count unchanged in Q3 2023.
BeOne Medicines Ltd made up 33.29% of Zeal Asset Management's portfolio in Q3 2023, its #2 holding.
Zeal Asset Management first reported a position in BeOne Medicines Ltd in Q4 2021 and has held it in 8 quarters since.
Zeal Asset Management's BeOne Medicines Ltd position peaked at $38.1M in Q1 2022.
201 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2023.

Based on Zeal Asset Management's 13F filing for Q3 2023, filed 8 Nov 2023.